Alpine Income Property Trust Launches Initial Public Offering
DAYTONA BEACH, Fla., Nov. 08, 2019 (GLOBE NEWSWIRE) — Alpine Income Property Trust, Inc. (the “Company” or “PINE”) announced today […]
Oncocyte Announces Strategic Support of GO2 Foundation for Lung Cancer
ALAMEDA, Calif., Nov. 08, 2019 (GLOBE NEWSWIRE) — OncoCyte Corporation (NYSE American: OCX), a molecular diagnostics company providing actionable answers […]
Centrexion Therapeutics Announces CNTX-4975 Data Presentations at the 2019 American College of Rheumatology Annual Meeting and the 2019 American Academy of Physical Medicine and Rehabilitation Annual Assembly
BOSTON, Nov. 08, 2019 (GLOBE NEWSWIRE) — Centrexion Therapeutics Corporation, a company focused on developing non-opioid, non-addictive therapies for the […]
Bio-Path Holdings to Announce Third Quarter 2019 Financial Results on November 15, 2019
HOUSTON, Nov. 08, 2019 (GLOBE NEWSWIRE) — Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense […]
Ovid Therapeutics Reports Third Quarter 2019 Financial Results and Recent Progress
Announced Positive Initial Results from the Ongoing ENDYMION trial with OV935 (Soticlestat) in Rare Epilepsies; Sustained and Progressively-Improving Median Seizure […]
Mersana Therapeutics Presents New Preclinical Data from Immunosynthen Platform at the Society for Immunotherapy of Cancer (SITC) 34th Annual Meeting
CAMBRIDGE, Mass., Nov. 08, 2019 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and […]
Immutep Presents Positive Interim Data From Phase II TACTI-002 Trial at SITC
Part A comprises NSCLC patients with all levels of PD-L1 expression, being an all comer trialPreliminary Overall Response Rate (ORR) […]
Selecta Biosciences Reports Third Quarter 2019 Financial Results and Provides Corporate Update
– Compelling preclinical data presented at the European Society of Gene and Cell Therapy Annual Congress demonstrates the potential for […]
Collegium to Participate in Upcoming Investor Conference
STOUGHTON, Mass., Nov. 08, 2019 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being […]
Axovant Announces Corporate Updates and Financial Results for Second Fiscal Quarter Ended September 30, 2019
First evidence of clinical stabilization in two children with Tay-Sachs disease that received AXO-AAV-GM2 presented at ESGCT in October 2019Continued […]
